http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-575745-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e559abcd8f120b071dc1162360867ffa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-52 |
filingDate | 2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7816a2dd1a68b01cd1a33f87e18b57a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_954034b0551d3669992be0e32d0d8162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e36c36ade48d21a10b9f11e46b513e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138b5c7a2c5f62df51543c5dfc9c5bb9 |
publicationDate | 2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-575745-A |
titleOfInvention | Preparation of azoxystrobin |
abstract | Disclosed is a process for preparing a compound of formula (I) such as azoxystrobin, which comprises either (a) reacting a compound of formula (II) with 2-cyanophenol, or a salt thereof, in the presence of between 0.1 and 40 mol % of 1,4-diazabicyclo[2.2.2]octane (DABCO), or (b) reacting a compound of the formula (III), with a compound of the formula (IV) or a salt thereof, in the presence of between 0.1 and 40 mol % of 1,4-diazabicyclo[2.2.2]octane; wherein W is the methyl (E)-2-(3-methoxy)acrylate group C(CO2CH3)=CHOCH3 or the methyl 2-(3,3-dimethoxy)propanoate group C(CO2CH3)CH(OCH3)2, or a mixture of the two groups, and wherein 1,4-diazabicyclo[2.2.2]octane is not mixed with the compound of formula (II) or the compound of formula (III) unless (i) 2-cyanophenol or the compound of formula (IV) is present; or (ii) 1,4-diazabicyclo[2.2.2]octane is present as an acid salt or (iii) conditions are such that 1,4-diazabicyclo[2.2.2]octane and the compound of formula (II) or the compound of formula (III) are not able to react with each other; with the proviso that when between 0.1 and 2 mol% 1,4-diazabicyclo[2.2.2]octane is used, the 1,4-diazabicyclo[2.2.2]octane is not added last. |
priorityDate | 2006-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.